H&F Corporate Investors VIII, Ltd.
CIK
1767563
Location
San Francisco, CA
Portfolio Value
Micro
$63,527,599
Diversification
Highly concentrated
Filing Date
Global Rank
#6,156
/ 8,232
▼ 1634
Top Industry
Health Information Services
100.0%
3Y Alpha vs SPY
-12.9%
Period ended 2 months ago
Filed May 11, 2026 · 33d
5 quarters · since Mar 2025
Clone Performance
May 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+12.9%
SPY
+27.1%
Annualised alpha
-12.9%
Max drawdown
−81.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Portfolio Trend
5 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $63,527,599 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
1 positions ·
$63,527,599 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CTEV |
Claritev Corp
Healthcare
|
Held | 3,887,858 | $63,527,599 | 100.00% |